NHG-Standaard
M78
3.2
Onlangs herzien
februari 2024
april 2025
R. Luchtwegen
Richtlijnen diagnostiek
Naar Volledige tekst ›Anamnese
Naar Volledige tekst ›Lichamelijk onderzoek
Naar Volledige tekst ›Aanvullend onderzoek
Naar Volledige tekst ›Evaluatie
Naar Volledige tekst ›Richtlijnen beleid
Naar Volledige tekst ›Voorlichting en advies
Naar Volledige tekst ›Niet-medicamenteuze behandeling
Naar Volledige tekst ›Medicamenteuze behandeling
Naar Volledige tekst ›Antibiotica
Naar Volledige tekst ›Controles
Naar Volledige tekst ›Consultatie en verwijzing
Naar Volledige tekst ›Kinkhoest
Naar Volledige tekst ›Risicofactoren voor een ernstig beloop
Naar Volledige tekst ›Richtlijnen diagnostiek
Naar Volledige tekst ›Aanvullend onderzoek
Naar Volledige tekst ›Evaluatie
Naar Volledige tekst ›Richtlijnen beleid
Naar Volledige tekst ›Medicamenteuze behandeling
Naar Volledige tekst ›Consultatie en verwijzing
Naar Volledige tekst ›Achtergronden
Naar Samenvatting ›Begrippen
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Pathofysiologie
Naar Samenvatting ›Etiologie
Naar Samenvatting ›Klinisch beeld
Naar Samenvatting ›Beloop
Naar Samenvatting ›Risicofactoren
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Spoed
Naar Samenvatting ›Anamnese
Naar Samenvatting ›Lichamelijk onderzoek
Naar Samenvatting ›Onderzoek van de longen
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›CRP-bepaling
Naar Samenvatting ›X-thorax
Naar Samenvatting ›Onderzoek naar verwekkers
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Differentiaaldiagnose
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting en advies
Naar Samenvatting ›Niet-medicamenteuze behandeling
Naar Samenvatting ›Stomen en zoutoplossing
Naar Samenvatting ›Thuisarts
Naar Samenvatting ›Medicamenteuze behandeling
Naar Samenvatting ›Hoestprikkeldempende middelen en mucolytica
Naar Samenvatting ›Hoestprikkeldempende middelen
Naar Samenvatting ›Mucolytica
Naar Samenvatting ›Luchtwegverwijders
Naar Samenvatting ›Inhalatiecorticosteroïden
Naar Samenvatting ›Antibiotica bij pneumonie
Naar Samenvatting ›Antibiotica bij hoesten zonder pneumonie
Naar Samenvatting ›Controles
Naar Samenvatting ›Consultatie en verwijzing
Naar Samenvatting ›Bronchiolitis
Naar Samenvatting ›Achtergronden
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Etiologie
Naar Samenvatting ›Klinisch beeld
Naar Samenvatting ›Beloop
Naar Samenvatting ›Risicofactoren
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Spoed
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting en niet-medicamenteuze behandeling
Naar Samenvatting ›Medicamenteuze behandeling
Naar Samenvatting ›Controles
Naar Samenvatting ›Consultatie en verwijzing
Naar Samenvatting ›Kinkhoest
Naar Samenvatting ›Achtergronden
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Etiologie
Naar Samenvatting ›Klinisch beeld
Naar Samenvatting ›Beloop
Naar Samenvatting ›Risicofactoren
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Spoed
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting en niet-medicamenteuze behandeling
Naar Samenvatting ›Medicamenteuze behandeling
Naar Samenvatting ›Controles
Naar Samenvatting ›Consultatie en verwijzing
Naar Samenvatting ›Pseudokroep
Naar Samenvatting ›Achtergronden
Naar Samenvatting ›Epidemiologie
Naar Samenvatting ›Etiologie
Naar Samenvatting ›Klinisch beeld
Naar Samenvatting ›Beloop
Naar Samenvatting ›Risicofactoren
Naar Samenvatting ›Richtlijnen diagnostiek
Naar Samenvatting ›Spoed
Naar Samenvatting ›Aanvullend onderzoek
Naar Samenvatting ›Evaluatie
Naar Samenvatting ›Richtlijnen beleid
Naar Samenvatting ›Voorlichting en niet-medicamenteuze behandeling
Naar Samenvatting ›Milde pseudokroep
Naar Samenvatting ›Matig-ernstige en ernstige pseudokroep
Naar Samenvatting ›Thuisarts
Naar Samenvatting ›Medicamenteuze behandeling
Naar Samenvatting ›Milde pseudokroep
Naar Samenvatting ›Matig-ernstige pseudokroep
Naar Samenvatting ›Ernstige pseudokroep
Naar Samenvatting ›Controle
Naar Samenvatting ›Consultatie en verwijzing
Naar Samenvatting ›Referenties
- Irwin RS, French CL, Chang AB, Altman KW. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest 2018;153:196-209.
- Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129:1s-23s.
- Shields MD, Bush A, Everard ML, McKenzie S, Primhak R. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax 2008;63 Suppl 3:iii1-iii15.
- Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature. Ann Fam Med 2013;11:5-13.
- Van Vugt SF, Butler CC, Hood K, Kelly MJ, Coenen S, Goossens H, et al. Predicting benign course and prolonged illness in lower respiratory tract infections: a 13 European country study. Fam Pract 2012;29:131-8.
- Smith MP, Lown M, Singh S, Ireland B, Hill AT, Linder JA, Irwin RS. Acute cough due to acute bronchitis in immunocompetent adult outpatients: CHEST expert panel report. Chest 2020;157:1256-65.
- NVK. Richtlijn Onderste luchtweginfecties. Diagnostiek en behandeling van ongecompliceerde pneumonie bij kinderen in de tweede en derde lijn. (2015). Ga naar bron: NVK. Richtlijn Onderste luchtweginfecties. Diagnostiek en behandeling van ongecompliceerde pneumonie bij kinderen in de tweede en derde lijn. (2015).
- Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med 2016;14:552-66.
- Gillissen A, Richter A, Oster H. Clinical efficacy of short-term treatment with extra-fine HFA beclomethasone diproprionate in patients with post-infectious persistent cough. J Physiology and Pharmacology 2007;58:223-32.
- McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 2006;129:48s-53s.
- Graffelman AW, Knuistingh Neven A, le Cessie S, Kroes AC, Springer MP, Van den Broek PJ. Pathogens involved in lower respiratory tract infections in general practice. Br J Gen Pract 2004;54:15-9.
- Holm A, Nexoe J, Bistrup LA, Pedersen SS, Obel N, Nielsen LP, Pedersen C. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract 2007;57:547-54.
- . Ieven M, Coenen S, Loens K, Lammens C, Coenjaerts F, Vanderstraeten A, et al. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clin Microbiol Infect 2018;24:1158-63.
- Braeken DCW, Essig A, Panning M, Hoerster R, Nawrocki M, Dalhoff K, et al. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade. Infection 2021;49:533-7.
- Lagerström F, Bader M, Foldevi M, Fredlund H, Nordin-Olsson I, Holmberg H. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden. Clin Microbiol Infect 2003;9:645-52.
- Groeneveld GH, Van 't Wout JW, Aarts NJ, Van Rooden CJ, Verheij TJM, Cobbaert CM, et al. Prediction model for pneumonia in primary care patients with an acute respiratory tract infection: role of symptoms, signs, and biomarkers. BMC Infect Dis 2019;19:976.
- Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis 2017;65:1736-44.
- Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet 2021;398:906-19.
- Wittermans E, Vestjens SMT, Spoorenberg SMC, Blok WL, Grutters JC, Janssen R, et al. Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial. Eur Respir J 2021;58.
- Schweitzer VA, Van Heijl I, Boersma WG, Rozemeijer W, Verduin K, Grootenboers MJ, et al. Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial. Lancet Infect Dis 2022;22:274-83.
- Haak BW, Brands X, Davids M, Peters-Sengers H, Kullberg RFJ, van Houdt R, et al. Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study. Clin Infect Dis 2022;74:776-84.
- Postma DF, Van Werkhoven CH, Van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015;372:1312-23.
- Pereverzeva L, Uhel F, Peters Sengers H, Butler J, Van Vught LA, Burnham KL, et al. Blood leukocyte transcriptomes in Gram-positive and Gram-negative community-acquired pneumonia. Eur Respir J 2022;59.
- Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015;372:835-45.
- Group PS. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet 2019;394:757-79.
- Smith DK, Kuckel DP, Recidoro AM. Community-acquired pneumonia in children: rapid evidence review. Am Fam Physician 2021;104:618-25.
- Opstelten W, Bijlsma JW, Gelinck LB, Hielkema CM, Verheij TJ, Van Eden W. Verminderde immuniteit: risicogroepen en gevolgen voor de huisartspraktijk. Ned Tijdschr Geneeskd 2016;160:A9752.
- Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet 2017;389:211-24.
- Tijdink JM, Blanken MO, Bomt L. Nieuwe inzichten in epidemiologie en pathogenese van infecties met respiratoir syncytieel virus. Tijdschrift voor infectieziekten. 2007;2:137-42.
- Hoepelman IM, Van der Noordaa J, Sauerwein RW, Verbrugh HA. Microbiologie en Infectieziekten. Houten: Bohn Stafleu Van Loghum, 2002.
- Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293-9.
- Ebell MH, Chupp H, Cai X, Bentivegna M, Kearney M. Accuracy of signs and symptoms for the diagnosis of community-acquired pneumonia: a meta-analysis. Acad Emerg Med 2020;27:541-53.
- Marchello CS, Ebell MH, Dale AP, Harvill ET, Shen Y, Whalen CC. Signs and Symptoms That Rule out Community-Acquired Pneumonia in Outpatient Adults: A Systematic Review and Meta-Analysis. J Am Board Fam Med 2019;32:234-47.
- Thornton HV, Blair PS, Lovering AM, Muir P, Hay AD. Clinical presentation and microbiological diagnosis in paediatric respiratory tract infection: a systematic review. Br J Gen Pract 2015;65:e69-81.
- Hopstaken RM, Coenen S, Butler CC, Nelemans P, Muris JW, Rinkens PE, et al. Prognostic factors and clinical outcome in acute lower respiratory tract infections: a prospective study in general practice. Fam Pract 2006;23:512-9.
- Bont J, Hak E, Hoes AW, Schipper M, Schellevis FG, Verheij TJ. A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J 2007;29:969-75.
- SWAB. Richtlijn Management of community-acquired pneumonia in adults. (2016). Ga naar bron: SWAB. Richtlijn Management of community-acquired pneumonia in adults. (2016).
- Marsden PA, Woodhead M. Lower respiratory tract infection in the community: prognosis predictably difficult to predict. Prim Care Respir J 2012;21:11-3.
- Bont J, Hak E, Hoes AW, Macfarlane JT, Verheij TJ. Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool. Arch Intern Med 2008;168:1465-8.
- Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
- Francis NA, Cals JW, Butler CC, Hood K, Verheij T, Little P, et al. Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care. Prim Care Respir J 2012;21:65-70.
- Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25-76.
- Vos PJ, van Herwaarden CL. [Physical examination--percussion of the thorax]. Ned Tijdschr Geneeskd 1999;143:1812-5.
- Zaat JOM, Stalman WAM, Assendelft WJJ. Hoort, wie klopt daar? Een systematische literatuurstudie naar de waarde van anamnese en lichamelijk onderzoek bij verdenking op een pneumonie. Huis&Wet 1998;41:461-9.
- Moore M, Stuart B, Lown M, Van den Bruel A, Smith S, Knox K, et al. Predictors of adverse outcomes in uncomplicated lower respiratory tract infections. Ann Fam Med 2019;17:231-8.
- Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358-64.
- Minnaard MC, De Groot JAH, Hopstaken RM, Schierenberg A, De Wit NJ, Reitsma JB, et al. The added value of C-reactive protein measurement in diagnosing pneumonia in primary care: a meta-analysis of individual patient data. CMAJ 2017;189:E56-e63.
- Oostenbrink R, Thompson M, Lakhanpaul M, Steyerberg EW, Coad N, Moll HA. Children with fever and cough at emergency care: diagnostic accuracy of a clinical model to identify children at low risk of pneumonia. Eur J Emerg Med 2013;20:273-80.
- Van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, De Jong PA, Coenen S, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013;346:f2450.
- Schwartz M, Hardy V, Keppel GA, Alto W, Hornecker J, Robitaille B, et al. Patient willingness to have tests to guide antibiotic use for respiratory tract infections: from the WWAMI region practice and research network (WPRN). J Am Board Fam Med 2017;30:645-56.
- Lähde S, Jartti A, Broas M, Koivisto M, Syrjälä H. HRCT findings in the lungs of primary care patients with lower respiratory tract infection. Acta Radiol 2002;43:159-63.
- Cao AM, Choy JP, Mohanakrishnan LN, Bain RF, Van Driel ML. Chest radiographs for acute lower respiratory tract infections. Cochrane Database Syst Rev 2013;2013:CD009119.
- Tokar B, Ozkan R, Ilhan H. Tracheobronchial foreign bodies in children: importance of accurate history and plain chest radiography in delayed presentation. Clin Radiol 2004;59:609-15.
- Yzerman EP, Den Boer JW, Lettinga KD, Schellekens J, Dankert J, Peeters M. Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands. J Clin Microbiol 2002;40:3232-6.
-
Lagerström F, Fredlund H, Holmberg H. Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care. Scand J Prim Health Care 2004;22:83-6.
- Bartlett JG. Diagnostic test for etiologic agents of community-acquired pneumonia. Infect Dis Clin North Am 2004;18:809-27.
- García-Vázquez E, Marcos MA, Mensa J, de Roux A, Puig J, Font C, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med 2004;164:1807-11.
- Tschopp JM, Bintcliffe O, Astoul P, Canalis E, Driesen P, Janssen J, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J 2015;46:321-35.
- Brown KK. Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. Chest 2006;129:180s-5s.
- Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63 Suppl 5:v1-58.
- Smith JA, Woodcock A. Chronic cough. N Engl J Med 2016;375:1544-51.
- Widdicombe JG. Advances in understanding and treatment of cough. Monaldi Arch Chest Dis 1999;54:275-9.
- Gergen PJ. Environmental tobacco smoke as a risk factor for respiratory disease in children. Respir Physiol 2001;128:39-46.
- Johansson A, Ludvigsson J, Hermansson G. Adverse health effects related to tobacco smoke exposure in a cohort of three-year olds. Acta Paediatr 2008;97:354-7.
- Jurado D, Muñoz C, Luna Jde D, Muñoz-Hoyos A. Is maternal smoking more determinant than paternal smoking on the respiratory symptoms of young children? Respir Med 2005;99:1138-44.
- Håberg SE, Stigum H, Nystad W, Nafstad P. Effects of pre- and postnatal exposure to parental smoking on early childhood respiratory health. Am J Epidemiol 2007;166:679-86.
- DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004;113:1007-15.
- Pattenden S, Antova T, Neuberger M, Nikiforov B, De Sario M, Grize L, et al. Parental smoking and children's respiratory health: independent effects of prenatal and postnatal exposure. Tob Control 2006;15:294-301.
- KNMP Kennisbank. Geraadpleegd 23 maart 2023. Ga naar bron: KNMP Kennisbank. Geraadpleegd 23 maart 2023.
- NKFK. Geraadpleegd 1 september 2021. Ga naar bron: NKFK. Geraadpleegd 1 september 2021.
- Lam SHF, Homme J, Avarello J, Heins A, Pauze D, Mace S, et al. Use of antitussive medications in acute cough in young children. J Am Coll Emerg Physicians Open 2021;2:e12467.
- Abuelgasim H, Albury C, Lee J. Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis. BMJ Evid Based Med 2021;26:57-64.
- Luinenburg JJ, Ensink-Dost D, Lelie-van der Zande ACAM. Standaarden voor zelfzorg: geneesmiddel informatie centrum: KNMP, 2017.
- Oduwole O, Udoh EE, Oyo-Ita A, Meremikwu MM. Honey for acute cough in children. Cochrane Database Syst Rev 2018;4:CD007094.
- Cohen HA, Rozen J, Kristal H, Laks Y, Berkovitch M, Uziel Y, et al. Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study. Pediatrics 2012;130:465-71.
- Shadkam MN, Mozaffari-Khosravi H, Mozayan MR. A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents. J Altern Complement Med 2010;16:787-93.
- Llor C, Moragas A, Ouchi D, Monfà R, Garcia-Sangenís A, Gómez-Lumbreras A, et al. Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Fam Pract 2023;40:407-13.
- Nishimura T, Muta H, Hosaka T, Ueda M, Kishida K. Multicentre, randomised study found that honey had no pharmacological effect on nocturnal coughs and sleep quality at 1-5 years of age. Acta Paediatr 2022;111:2157-64.
- Waris A, Macharia M, Njeru EK, Essajee F. Randomised double blind study to compare effectiveness of honey, salbutamol and placebo in treatment if cough in childeren with common cold. East Afr Med J 2014;91:50-6.
- Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM, Jr. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007;161:1140-6.
- Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev 2013:CD006323.
- Schaefer A, Kehr MS, Giannetti BM, Bulitta M, Staiger C. A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575(®)) vs. placebo in the treatment of adults with acute cough. Pharmazie 2016;71:504-9.
- Schaefer A, Ludwig F, Giannetti BM, Bulitta M, Wacker A. Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults. ERJ Open Res 2019;5.
- Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev 2014;2014:CD001831
- Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 1992;17:175-80.
- Korppi M, Laurikainen K, Pietikäinen M, Silvasti M. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991;80:969-71.
- Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004;114:e85-90.
- Bhattacharya M, Joshi N, Yadav S. To compare the effect of dextromethorphan, promethazine and placebo on nocturnal cough in children aged 1-12 y with upper respiratory infections: a randomized controlled trial. Indian J Pediatr 2013;80:891-5.
- Chalumeau M, Duijvestijn YC. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev 2013:CD003124.
- Becker LA, Hom J, Villasis-Keever M, Van der Wouden JC. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev 2015;2015:CD001726.
- Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008;186:369-74
- Tukiainen H, Karttunen P, Silvasti M, Flygare U, Korhonen R, Korhonen T, et al. The treatment of acute transient cough: a placebo-controlled comparison of dextromethorphan and dextromethorphan-beta 2-sympathomimetic combination. Eur J Respir Dis 1986;69:95-9.
- Melbye H, Aasebø U, Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Fam Pract 1991;8:216-22.
- Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994;39:437-40.
- Littenberg B, Wheeler M, Smith DS. A randomized controlled trial of oral albuterol in acute cough. J Fam Pract 1996;42:49-53.
- Bernard DW, Goepp JG, Duggan AK, Serwint JR, Rowe PC. Is oral albuterol effective for acute cough in non-asthmatic children? Acta Paediatr 1999;88:465-7.
- El-Gohary M, Hay AD, Coventry P, Moore M, Stuart B, Little P. Corticosteroids for acute and subacute cough following respiratory tract infection: a systematic review. Fam Pract 2013;30:492-500.
- Ponsioen BP, Hop WC, Vermue NA, Dekhuijzen PN, Bohnen AM. Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J 2005;25:147-52.
- Pornsuriyasak P, Charoenpan P, Vongvivat K, Thakkinstian A. Inhaled corticosteroid for persistent cough following upper respiratory tract infection. Respirology 2005;10:520-4.
- Pakhale S, Mulpuru S, Verheij TJ, Kochen MM, Rohde GG, Bjerre LM. Antibiotics for community-acquired pneumonia in adult outpatients. Cochrane Database Syst Rev 2014;2014:CD002109.
- Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev 2013;2013:CD004874.
- SWAB. NethMap. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands (2021) Ga naar bron: SWAB. NethMap. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands (2021)
- Maimon N, Nopmaneejumruslers C, Marras TK. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J 2008;31:1068-76.
- Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330:456.
- Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2015;1:CD004875.
- Murphy S, Thomson L. NICE community-acquired pneumonia guideline review. Arch Dis Child Educ Pract Ed 2021;106:296-8.
- Van de Garde EM, Natsch S, Prins JM, Van der Linden PD. Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome. BMJ Open 2015;5:e006892.
- Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, et al. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. Jama 2021;326:1713-24.
- Li Q, Zhou Q, Florez ID, Mathew JL, Shang L, Zhang G, et al. Short-course vs long-course antibiotic therapy for children with nonsevere community-acquired pneumonia: a systematic review and meta-analysis. JAMA Pediatr 2022;176:1199-207.
- MASCOT Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41.
- Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004;328:791.
- Greenberg D, Givon-Lavi N, Sadaka Y, Ben-Shimol S, Bar-Ziv J, Dagan R. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. Pediatr Infect Dis J 2014;33:136-42.
- Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Phiri M, Schmicker R, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children. N Engl J Med 2020;383:13-23.
- López-Alcalde J, Rodriguez-Barrientos R, Redondo-Sánchez J, Muñoz-Gutiérrez J, Molero García JM, Rodríguez-Fernández C, et al. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev 2018;9:CD009070.
- El Moussaoui R, De Borgie CA, Van den Broek P, Hustinx WN, Bresser P, Van den Berk GE, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332:1355.
- Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet 2021;397:1195-203.
- Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2017;6:CD000245.
- Mittl RL, Jr., Schwab RJ, Duchin JS, Goin JE, Albeida SM, Miller WT. Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med 1994;149:630-5.
- El Solh AA, Aquilina AT, Gunen H, Ramadan F. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc 2004;52:224-9.
- Bruns AH, Oosterheert JJ, Prokop M, Lammers JW, Hak E, Hoepelman AI. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis 2007;45:983-91.
- Rome L, Murali G, Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am 2001;85:1511-30, xi.
- Holmberg H, Kragsbjerg P. Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up. Scand J Infect Dis 1993;25:93-100.
- Gibson SP, Weir DC, Burge PS. A prospective audit of the value of fibre optic bronchoscopy in adults admitted with community acquired pneumonia. Respir Med 1993;87:105-9.
- Nivel. Cijfers ziekten op jaarbasis – hoe gezond is Nederland? Geraadpleegd 23 augustus 2021. Ga naar bron: Nivel. Cijfers ziekten op jaarbasis – hoe gezond is Nederland? Geraadpleegd 23 augustus 2021.
- Hall CB. Respiratory syncytial virus: A continuing culprit and conundrum. J Pediatr 1999;135:2-7.
- NVK. Richtlijn Bronchiolitis. (2012). Ga naar bron: NVK. Richtlijn Bronchiolitis. (2012).
- Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J 2007;30:1158-66.
- Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2014;2014:CD001266.
- Wilcox CR, Holder B, Jones CE. Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy. Front Immunol 2017;8:1294.
- Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2007:CD004404.
- Wang K, Bettiol S, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, Harnden A. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev 2014;2014:Cd003257.
- Bjornson CL, Johnson DW. Croup. Lancet 2008;371:329-39.
- Schers H, Bor H, Van den Hoogen H, Van Weel C. What went and what came? Morbidity trends in general practice from the Netherlands. Eur J Gen Pract 2008;14 Suppl 1:13-24.
- Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child 1978;132:484-7.
- Johnson DW. Croup. BMJ Clin Evid 2014;2014.
- Moore M, Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev 2006:CD002870.
- Roorda RJ, Walhof CM, Brand PL. [Treatment of subglottic laryngitis (pseudocroup): steroids instead of steam]. Ned Tijdschr Geneeskd 1998;142:1658-62.
- Gates A, Gates M, Vandermeer B, Johnson C, Hartling L, Johnson DW, Klassen TP. Glucocorticoids for croup in children. Cochrane Database Syst Rev 2018;8:CD001955.
- Bjornson CL, Klassen TP, Williamson J, Brant R, Mitton C, Plint A, et al. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med 2004;351:1306-13.
- Cruz MN, Stewart G, Rosenberg N. Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics 1995;96:220-3.
- Dobrovoljac M, Geelhoed GC. How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emerg Med Australas 2012;24:79-85.
- Geelhoed GC, Turner J, Macdonald WB. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ 1996;313:140-2.
- Johnson DW, Schuh S, Koren G, Jaffee DM. Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med 1996;150:349-55.
- Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998;339:498-503.
- Klassen TP, Feldman ME, Watters LK, Sutcliffe T, Rowe PC. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994;331:285-9.
- Luria JW, Gonzalez-del-Rey JA, DiGiulio GA, McAneney CM, Olson JJ, Ruddy RM. Effectiveness of oral or nebulized dexamethasone for children with mild croup. Arch Pediatr Adolesc Med 2001;155:1340-5.
- Fifoot AA, Ting JY. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emerg Med Australas 2007;19:51-8.
- Anonymous. Ambulancezorg Nederland. Protocol Ambulancezorg (LPA). Herziene versie 8.1. Zwolle, Stichting LAMP: 2016.